May 9, 2018: Upcoming Webinar Reveals Science Behind DDS-1
Discover the DDS-1 Difference with UAS Labs
The team at UAS Labs will be hosting a live webinar and Q&A session on the clinically proven, world-renowned DDS®-1 strain of Lactobacillus acidophilus.
The DDS®-1 strain of Lactobacillus acidophilus is one of the longest studied probiotic strains, with over 35 years of clinical research. This unique strain has been shown to be well-tolerated in virtually all age groups and is recognized for the many ways it supports digestive and immune health. It has been used in laboratory, animal, and human clinical studies, and shown to have a positive effect on digestion, immune function, and skin conditions. As the exclusive supplier, UAS Labs is proud to have brought together the science and success of the DDS®-1 strain. As a leader in the industry, UAS will continue to invest in the clinical roadmap of both the single strain and its use in blends.
Join Dr. Gregory Leyer and Kevin Mehring on May 9th to learn more about the past, present and future of DDS®-1 and how it can positively benefit your business!
|Time||10:00 AM CST|
|Date||9 May 2018|
|Speakers:||Kevin Mehring, President / CEO|
|Dr. Gregory Leyer, Chief Scientific Officer|